IRIS
ROSSI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.391
EU - Europa 1.062
AS - Asia 696
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
SA - Sud America 1
Totale 3.160
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.347
CN - Cina 396
FI - Finlandia 277
IE - Irlanda 272
SE - Svezia 230
SG - Singapore 168
DE - Germania 134
TR - Turchia 115
UA - Ucraina 98
CA - Canada 44
BE - Belgio 16
IN - India 10
GB - Regno Unito 9
NL - Olanda 8
IR - Iran 7
FR - Francia 6
CI - Costa d'Avorio 5
IT - Italia 5
EU - Europa 4
HU - Ungheria 3
LT - Lituania 3
AT - Austria 1
AU - Australia 1
BR - Brasile 1
Totale 3.160
Salva come PNG Salva come JPEG
Città #
Chandler 346
Dublin 272
Jacksonville 224
Singapore 126
Izmir 115
Beijing 87
Dearborn 82
Nanjing 69
Ashburn 58
San Mateo 56
Boardman 48
Princeton 48
Shanghai 44
Toronto 35
Des Moines 30
Shenyang 28
Ann Arbor 26
Düsseldorf 26
Kunming 24
Nanchang 19
Woodbridge 18
Brussels 16
Leawood 16
Wilmington 16
Hebei 14
Helsinki 13
Jinan 11
Hefei 10
Santa Clara 10
Guangzhou 8
Monmouth Junction 7
Seattle 7
Tianjin 7
Augusta 6
Fuzhou 6
Ottawa 6
Abidjan 5
Huizen 5
Zhengzhou 5
Changsha 4
Grafing 4
Jiaxing 4
London 4
Phoenix 4
Sabz 4
Ardabil 3
Fremont 3
Haikou 3
Hangzhou 3
Ningbo 3
Rockville 3
Taiyuan 3
Dallas 2
Falls Church 2
Forlì 2
Lanzhou 2
New York 2
Amsterdam 1
Baotou 1
Borås 1
Bremen 1
Changchun 1
Chaoyang 1
Chongqing 1
Costa Mesa 1
Frankfurt am Main 1
Geislingen an der Steige 1
Hobart 1
Hull 1
Langfang 1
Los Angeles 1
New Delhi 1
Parma 1
Pompano Beach 1
Pune 1
Quzhou 1
Redmond 1
Shaoxing 1
Swindon 1
Vienna 1
Wenzhou 1
Wuhan 1
Xian 1
Xiangfen 1
Totale 2.031
Salva come PNG Salva come JPEG
Nome #
Inhibition by somatostatin of LH-RH-induced LH release in normal menstruating women. 99
Oxytocin reduces angiotensin II-induced ACTH release in men. 82
Effect of muscarinic and nicotinic-cholinergic blockade on the glucagon response to insulin-induced hypoglycemia in normal men. 79
Intravenously infused Substance P is unable to change basal and TRH-stimulated PRL secretion in normal men. 77
Oxytocin does not modify the PRL response to metoclopramide in normal women. 77
Effect of oxytocin on growth hormone (GH) secretion in response to arginin-vasopressin. 76
Reduction of lysine vasopressin induced GH, but not ACTH release in elderly men. 76
Effect of pharmacological doses of oxytocin on insulin response to glucose in man. 76
Histaminergic H1 and H2 receptors do not mediate cortisol release in response to naloxone in normal men. 75
Oxytocin administration does not alter growth hormone response to insulin induced hypoglycemia in normal men. 75
TSH and PRL responses to metoclopramide and TRH in normal elderly men. 75
Growth hormone responses to GHRH, clonidine and insulin-induced hypoglycemia in normal weight bulimic women. 75
Lysine-vasopressin inhibits the effect of oxytocin on the insulin response to glucose in normal man. 74
Arginine vasopressin secretion in non obese women with polycystic ovary syndrome. 73
Effect of lysine vasopressin on basal and TRH stimulated TSH and PRL release in normal men. 72
Oxytocin Response to challenging stimuli in elderly men. 71
Dopaminergic, but not cholinergic involvement in regulation of hypoglycemia-induced oxytocin release in man. 69
The gabaergic control of prolactin release is not affected by insulin-dependent diabetes mellitus: evidence from studies with sodium valproate. 69
Lysine-vasopressin does not affect basal and LH-RH stimulated LH and FSH release during the menstrual cycle of normal women. 69
Abnormal arginine vasopressin responses to metoclopramide and insulin induced hypoglycemia in type I diabetes mellitus. 68
The infusion of somatostatin reduces the arginine vasopressin response to insulin induced hypoglycemia in man. 68
Thyrotropin-releasing hormone does not inhibit lysine vasopressin-induced growth hormone secretion in normal men. 67
Hypoglycemia induced arginine vasopressin and oxytocin release is mediated by glucoreceptors located inside the blood brain barrier 67
Somatostatin does not modulate arginine vasopressin and oxytocin responses to angiotensin II 66
Effect of Naloxone on the LH response to intravenously-infused substance P in normal men 66
Different effects of baclofen on LH and cortisol responses to naloxone in normal men. 66
Abnormal growth hormone and cortisol but not thyroid stimulating hormone response to an intravenous glucose tolerance test in normal weight bulimic women. 66
Effect of histaminergic H1- and H2-receptor antagonist on neurophysin release in response to nicotine from cigarette smoking in normal men. 65
Effect of naloxone on oxytocin-induced cortisol decrease in normal men. 64
Failure of metergoline to antagonize naloxone induced cortisol rise in man. 63
Muscarinic cholinergic and histaminergic H1 and H2 receptors are not involved in the LH response to naloxone in man. 63
Oxytocin does not modify glucagon- or calcitonin induced ACTH/Cortisol rise in humans. 62
Different effects of metoclopramide and domperidone on arginine-vasopressin secretion in man. 62
Effect of potentiation of cholinergic tone by pyridostigmine on the growth hormone (GH) response to GH-releasing hormone in elderly men. 61
Naloxone does not alter the effect of a gamma amino-butyric acid derivative, baclofen, on GH release in man. 61
Effect of domperidone on cortisol secretion in normal men. 59
Endogenous opioid mediation of the inhibitory effect of ethanol on the prolactin response to breast stimulation in normal women. 59
Cholinergic- muscarinic-receptors do not mediate growth hormone release in response to baclofen, a gamma aminobutyric acid agonist, in humans 59
Effect of naloxone on neurophysin secretion induced by nicotine in man. 57
Luteinizing hormone response to an intravenous infusion of substance P in normal men. 57
Evaluation of oxytocin administration on luteinizing hormone and follicle stimulating hormone response to luteinizing hormone-releasing-hormone during the menstrual cycle of normal women. 55
Gabaergic mediation of the inhibitory effect of endogenous opioids on the arginine vasopressin and oxytocin responses to nicotine from cigarette smoking 54
Serotonergic control of TSH and PRL secretion in obese men. 53
Simultaneous inhibition by pirenzepine of the GH responses to Gn-RH and TRH in insulin dependent diabetics and in patients with major depression. 52
Stimulation of ACTH/cortisol by intravenously infused substance P in normal men: Inhibition by sodium valproate. 50
Failure of naloxone to modify anterior pituitary pattern in insulin-dependent diabetics. 47
Restoration of normal GH responsiveness to GHRH in normal aged men by infusion of low amounts of theophylline. 43
Intravenously infused substance P enhances basal and growth hormone (GH)-releasing hormone stimulated GH secretion. 42
Totale 3.161
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.817
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.817
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020330 0 0 0 0 50 64 89 7 45 28 5 42
2020/2021289 0 48 0 0 39 0 0 2 82 1 114 3
2021/2022233 1 2 1 6 5 6 34 43 11 18 15 91
2022/20231.043 98 129 75 80 73 122 4 82 347 3 25 5
2023/2024224 18 28 4 7 23 38 2 31 8 5 25 35
2024/2025264 34 54 75 52 49 0 0 0 0 0 0 0
Totale 3.161